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A B S T R A C T
The aim of this study is to report the antidiabetic properties of a beverage developed from
roselle calyx and selected fruits in male albino rats. The beverage was designed to contain
30% pawpaw (Carica papaya L.), 10% grapefruit (Citrus paradisi), 20% guava leaves (Psidium
guajava L.) and 40% roselle calyx aqueous extracts. Four groups of five rats each were ac-
climatized on pelletized mouse chow for seven days, after which diabetes was induced by
a single ip injection of alloxan in all groups except group 1, which served as control. Group
2 served as negative control while groups 3 and 4 were treated with the beverage at 2.5 and
5 ml/kg bw respectively. Food intake, body weight, and blood glucose levels were moni-
tored. They were sacrificed by cervical dislocation after a 2 week treatment. Blood serum
was analysed to evaluate insulin levels, β cell function, insulin resistance and lipid profile.
Histological studies were carried out on pancreatic tissues. Treatment with both doses of
the beverage led to a significant reduction (p < 0.05) in blood glucose, total cholesterol tri-
glyceride, LDL and increased HDL levels. It also improved serum insulin levels, β cell function,
reduced insulin resistance and restored pancreatic beta cells compared to the diabetic group.
These antidiabetic properties may be as a consequence of modulation of the β-cell func-
tion, reduction of insulin resistance and preservation/restoration of β-cell integrity. However,
treatment with the single dose showed signs of hyperinsulinaemia.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Beni-Suef Uni-
versity. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
The rising bane of diabetes especially in most developing coun-
tries has become a major global health issue (Erukainure et al.,
2013). In 2010, 12.1 million people were estimated to be dia-
betic in Africa, and this is expected to rise to 23.9 million by
2030 (Sicree et al., 2009). Though it is mostly common among
the elderly in most populations, prevalence rates have been
predicted to significantly rise among the young and produc-
tive populations in the developing world (Gomes et al., 2006).
Characterized by hyperglycaemia, diabetes is a metabolic dis-
order that affects carbohydrate, protein and lipid metabolism
(Maritimi et al., 2003). This may be due to inadequate insulin
release as seen in type 1 diabetes or insulin resistance result-
ing to type 2 diabetes (Meral et al., 2004). It increases the risk
of several complications such as nephropathy, microangiopathy
and retinopathy (Barar, 2000).
Increasing interests in complementary and alternative medi-
cine have led to the development and search of novel therapy
for diabetes (Yeh et al., 2002). Over the years, plants have been
used in the treatment and management of diabetes (Gupta
et al., 2005). This has been attributed to the presence of
phytochemicals which are remedial against diabetes and other
ailments.
Fruits have been well documented to be medicinal.This has
been attributed to their antioxidant properties owing to the in-
tegrated action of oxygen radical scavengers such as β-carotene
and ascorbic acid, calcium and dietary fibre (Bhardwaj and
Pandey, 2011). Their daily consumption has been linked with
reduced risk of cancer, cardiovascular disease, diabetes, stress
and fatigue (Erukainure et al., 2012). Of particular interests are
pawpaw (Carica papaya L.) and grape (Citrus paradisi) fruits.Their
antidiabetic properties have been documented in several studies
(Erukainure et al., 2012; Lans, 2006). Due to their perishable
nature and poor storage facilities, the post-harvest shelf life
of these fruits is very limited thereby leading to wastage
(Bhardwaj and Pandey, 2011; Nwachukwu et al., 2010). Devel-
opment of ready-to-serve beverage from blends of these fruits
is a convenient option for their utilization and reduces post-
harvest losses (Bhardwaj and Pandey, 2011). Blending juices with
other medicinal plants such roselle calyx (Hibiscus sabdariffa)
and guava leaves (Psidium guajava L.) improves the medicinal
properties (Erukainure et al., 2012).The protective effect of these
plants against diabetes has been reported. Guava leaves have
been shown to inhibit increases in plasma glucose level in dia-
betic rats (Mazumdara et al., 2015). Aqueous extract of roselle
calyx has been demonstrated as having beneficial effects on
anti-oxidation and lipid lowering in experimental diabetic
studies (Wang et al., 2011). A blend of the aforementioned fruits
and medicinal plants to form a natural health drink suitable
for the treatment and/or management of diabetes and its
related complication has been reported (Erukainure et al., 2012;
Okafor et al., 2010). Erukainure et al. (2012) reported the pro-
tective role of these blends against hyperglycaemia-induced
oxidative stress in testicular tissues and sperm cells in rats.
This paper aims to assess the anti-diabetic and/or
hypoglycaemic effect of blends of pawpaw and grape fruits with
aqueous extracts of guava leaves and roselle calyx in male
albino rats.
2. Materials and methods
2.1. Plant materials
Unripe pawpaw fruits (Cg variety), grape fruits, and roselle calyx
were purchased from Mushin market, Lagos Nigeria. Guava
leaves were obtained from Ikorodu, Lagos, Nigeria. The fruits
were washed and peeled, while the guava leaves and roselle
calyx were sorted and washed. Production of beverage was
carried out according to the method described by Okafor et al.
(2010). The beverage was designed to contain 30% pawpaw
(C. papaya L.), 10% grapefruit (C. paradisi), 20% guava leaves
(P. guajava L.) and 40% roselle calyx aqueous extracts.
2.2. Animals
Twenty male albino rats of Wistar strain weighing about 150–
200 g were used for the study. They were fed on standard rat
pellet diet and allowed to adapt for one week. They were pro-
vided water ad libitum and maintained under standard
laboratory conditions of natural photo period of 12-hr light–
dark cycle. The animals used in the present study were
maintained in accordance with the approval of the Animal
Ethical Committee, Federal Institute of Industrial Research,
Lagos, Nigeria.
2.3. Induction of diabetes
Diabetes was induced by a single intraperitoneal injection of
150 mg/kg of alloxan monohydrate in normal saline water in
a volume of about 3 ml (Viswanathaswamy et al., 2011). After
72 hours, the diabetic rats (glucose level > 150 mg/dl) were sepa-
rated and used for the study.
2.4. Experimental design
The rats were divided into four groups, each consisting of five
animals.
Group 1 – consisted of normal rats and fed on pelletized
mouse chows
Group 2 – consisted diabetic rats with no treatment
administered
Group 3 – consisted of diabetic rats and treated with 2.5 ml/
kg bw of the developed beverage
Group 4 – consisted of diabetic rats and treated with 5.00 ml/
kg bw of the developed beverage
All rats were fed on pelletized mouse chows and were moni-
tored daily for food and water intake, and body weight. The
developed beverage was orally administered, groups 1 and 2
were orally administered with water. Blood glucose levels of
the rats were monitored on a weekly basis with a glucometer.
Treatment lasted for 14 days after induction. At the end of the
treatment trials, the rats were fasted overnight and sacri-
ficed by cervical dislocation.
The dose of the developed beverage and period of treat-
ment were selected on the basis of previous studies by
Erukainure et al. (2014).
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2.5. Serum preparation
Blood was collected with a 5 ml syringe and needle by cardiac
puncture. It was centrifuged at 3000 rpm for 10 min and the
serum (supernatant) was analysed to evaluate serum insulin
level by ELISA method using insulin kit (DRG International, Inc,
USA) according to manufacturer’s protocol.
Insulin resistance (IR) and β-cell (β) function were quanti-
fied using the homeostatic model assessment (HOMA) formula
(Hermans and Lambert, 2002).
HOMA-IR
Fasting blood glucose Fasting serum insulin
=
×
405
(1)
HOMA-
Fasting insulin
Fasting glucose
β = ×
×
360
63
(2)
Insulin sensitivity (IS) was quantified using the quantita-
tive insulin sensitivity check index (QUICKI) which is derived
using the inverse of the sum of the logarithms of the fasting
insulin and fasting glucose (Yokoyama et al., 2003).
QUICKI
fasting insulin fasting glucose
= ( ) + ( )
1
log log
(3)
2.6. Serum lipid profile and atherogenic indices
Serum total cholesterol, triglyceride and high density lipopro-
tein (HDL) were measured by enzymatic colorimetric method
using Randox kits. The concentration of very low density li-
poprotein (vLDL) and low-density lipoprotein (LDL) cholesterol
was calculated by the formula of Friedwald et al. (1972).
Atherogenic Index (AI) and Atherogenic Index of Plasma (AIP)
were calculated as described by Takasaki (2005) and Onat et al.
(2010) respectively. Cardiac Risk Ratio (CRR) and Atherogenic
Coefficient (AC) were calculated according to the methods de-
scribed by Ikewuchi and Ikewuchi (2009).
2.7. Histopathology
Pancreatic tissues from the sacrificed rats were sliced to a thick-
ness of 3 mm and arranged in a tissue cassette with attached
label. The tissues were processed using an automated tissue
processor (Leitz 2005 model) according to manufacturer’s
protocol.
2.8. Statistical analysis
All samples were analysed in triplicate and repeated at least
thrice for liability of data. Data were subjected to post-hoc test
and statistical significance was established using one-way
analysis of variance (ANOVA). Results were reported as
mean + standard deviation. Significant difference was estab-
lished at P < 0.05. Statistical analyses were carried out using
SPSS for Windows, version 15.0 (SPSS Inc., Chicago, IL).
3. Results
There was no significant difference in food consumed and food
efficiency ratio (FER) in all experimental groups as depicted in
Table 1. Significant reduced body weight was observed in rats
treated with single dose.
Induction of diabetes led to significant increase (p < 0.05)
in blood glucose level as shown in Fig. 1. Treatment with single
and double dose of the beverage significantly (p < 0.05) reduced
the blood glucose level.
Significant reduced (p < 0.05) serum insulin level was ob-
served in the diabetic group as shown in Fig. 2. This was
significantly increased on treatment with the beverage, with
Table 1 – Food intake, weight gain, and food efficiency ratio of experimental animals.
Parameters Group 1 Group 2 Group 3 Group 4
Weight gain (g/day) 36.93 ± 5.02c 21.1 ± 2.13c,d −4.18 ± 0.10a,b,d 21.66 ± 3.35c
Food consumed (g/day) 86.25 ± 10.02 75.00 ± 15.00 66.50 ± 9.08 77.75 ± 18.99
FER* 0.43 ± 0.18 0.28 ± 0.22 −0.06 ± 0.15 0.28 ± 0.20
Note: Values = mean + SD; n = 5.
a Statistically significant (p < 0.05) as compared with group 1.
b Statistically significant (p < 0.05) as compared with group 2.
c Statistically significant (p < 0.05) as compared with group 3.
d Statistically significant (p < 0.05) as compared with group 4.
* Food efficiency ratio = body weight gain/food intake.
Fig. 1 – Fasting blood glucose level of experimental groups.
Note: Values = mean ± SD; n = 5. a, statistically significant
(p < 0.05) as compared with group 1; b, statistically
significant (p < 0.05) as compared with group 2; c,
statistically significant (p < 0.05) as compared with group 3;
d, statistically significant (p < 0.05) as compared with
group 4.
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rats treated on single dose showing a rather higher level as com-
pared to the normal (control) group.
Effect of the beverage on insulin resistance and sensitiv-
ity is shown in Fig. 3. Significant increase in insulin resistance
was observed in rats treated with single dose of the bever-
age; this was followed by the untreated diabetic rats, while rats
treated with double dose had the lowest value. Reduced insulin
sensitivity was observed in rats on single dose treatment, this
was followed by the untreated, while the double dose treated
had the highest value.
Induction of diabetes led to significant reduction in β-cell
function as observed in the untreated diabetic rats (Fig. 4). This
was significantly reversed (p < 0.05) on treatment with the bev-
erage at both doses.
Induction of diabetes led to a significant increase in serum
cholesterol, triglyceride, vLDL and LDL levels and a reduced HDL
level as depicted in Fig. 5. This was significantly reduced on
treatment with the beverage.
Significant alteration in atherogenic indices was observed
in the experimental groups as shown in Fig. 6. The untreated
group displayed significantly higher (p < 0.05) levels. These
values were significantly lower (p < 0.05) in the treated groups.
Histological examination of the experimental rat pan-
creas is shown in Fig. 7. Reduced concentration and
hypocellularity of islets of Langerhans was observed in the un-
treated diabetic group (Fig. 7b). Treatment with single dose of
the beverage revealed a higher concentration of normo-
cellular islets of Langerhans (Fig. 7c).Treatment on double dose
revealed normo-cellular islets of Langerhans but not as con-
centrated as that of group 3 (Fig. 7d). All experimental groups
showed normal exocrine pancreas.
4. Discussion
Diabetes has been described as a looming epidemic and a major
threat to global public health, with the biggest impact on adults
of working age in developing countries (WHO and IDF, 2004;
Saini, 2010). It is characterised mainly by hyperglycaemia, insulin
resistance, dyslipidaemia and β cell failure (Vijayaraghavan,
2010). This study reports the therapeutic potentials of bever-
age produced from roselle calyx and selected fruit blends on
diabetic rats.
The importance of weight loss in diabetes particularly type
2 has been reported (Pi-Sunyer, 2005). However, in this study,
the rats were not obese making the observed weight loss in
the single dose treated group a serious concern.
Increased blood glucose has been recognized as the
primary defining characteristics of diabetes. Also known as
hyperglycaemia, it occurs as a result of low insulin levels and/
Fig. 2 – Fasting serum insulin level of experimental groups.
Note: Values = mean ± SD; n = 5. a, statistically significant
(p < 0.05) as compared with group 1; b, statistically
significant (p < 0.05) as compared with group 2; c,
statistically significant (p < 0.05) as compared with group 3;
d, statistically significant (p < 0.05) as compared with
group 4.
Fig. 3 – HOMA-IR and insulin sensitivity (QUIKI) of
experimental groups. Note: Values = mean ± SD; n = 5. a,
statistically significant (p < 0.05) as compared with group 1;
b, statistically significant (p < 0.05) as compared with group
2; c, statistically significant (p < 0.05) as compared with
group 3; d, statistically significant (p < 0.05) as compared
with group 4.
Fig. 4 – HOMA-β cells (β cell function) of experimental
groups. Note: Values = mean ± SD; n = 5. a, statistically
significant (p < 0.05) as compared with group 1; b,
statistically significant (p < 0.05) as compared with group 2;
c, statistically significant (p < 0.05) as compared with group
3; d, statistically significant (p < 0.05) as compared with
group 4.
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or by resistance to insulin at the cellular level (type 2 diabetes)
(Sommerfield et al., 2004). Both doses of treatment led to sig-
nificant (p < 0.05) reduction in blood glucose levels, indicating
a hypoglycaemic effect. This could be attributed to the re-
ported phytochemical and mineral properties of the beverage
(Okafor et al., 2010).The observed hypoglycaemic property could
also be attributed to the synergetic effect of the reported me-
dicinal properties of the fruits (Bhardwaj and Pandey, 2011).
The observed increase in serum insulin level by both doses
indicates insulin release by the pancreatic beta cells.This release
corroborates with the hypoglycaemic activity of the bever-
age. However, the serum insulin level of the single-dose treated
group was rather high which may suggest an occurrence of
hyperinsulinaemia owing to insulin resistance. This is further
portrayed by the high HOMA-IR and reduced QUIKI values which
indicate low insulin sensitivity. As a response to reduced insulin
sensitivity, insulin secretion is theoretically expected to in-
crease (Dixon et al., 2003). Insulin resistance is the core
metabolic abnormality in type 2 diabetes and has been asso-
ciated with most diabetic complications (Monzillo and Hamdy,
2003). The increased beta cell function also correlated with the
observed increased insulin level of the treated groups, indi-
cating reversibility of beta cell dysfunction with hypoglycaemic
activity.
Dyslipidaemia has been associated with the early stage of
diabetes (Adiels et al., 2008). It is characterized by elevated tri-
glyceride levels, low high-density lipoprotein cholesterol (HDL)
levels, and a dominance of low-density lipoprotein (LDL) par-
ticles (Erukainure et al., 2014). These were observed in the
untreated diabetic group. However, treatment on both doses
led to an anti-dyslipidaemic effect. Raised levels of free fatty
acids, cytosolic triglycerides have been associated with insulin
resistance and suggested to affect beta cell function in dia-
betics (Bakker et al., 2000; Dixon et al., 2003). Therefore, the
improved insulin sensitivity and beta cell function could provide
a possible explanation for the reversibility (Dixon et al., 2003).
An atherogenic lipid triad of high serum levels of triglyc-
erides, HDL and preponderance of small, dense LDL particles
has been associated with atherogenesis in diabetes (Nesto, 2005).
It is aggravated by insulin resistance and/or metabolic syn-
drome. Higher levels of atherogenic index (AI), atherogenic index
of plasma (AIP), cardiac risk ratio (CRR) and atherogenic coef-
ficient (AC) observed in the untreated diabetic group indicate
an occurrence of atherogenesis. This can be attributed to the
reduced serum insulin level and increased insulin resistance.
Atherogenic indices are powerful indicators of the risk of car-
diovascular disease (CVD); the higher the value, the higher the
risk of developing the disease and vice versa (Ikewuchi and
Ikewuchi, 2009). The reduced levels in the treated group could
thus be attributed to the increased serum insulin level and im-
proved insulin sensitivity. Thus, indicating the protective
potential of the beverage against diabetic-induced CVD.
Histopathological studies revealed reduction in the con-
centration and hypocellularity of islets of Langerhans in the
Fig. 5 – Lipid profile of experimental groups. Note: Values = mean ± SD; n = 5. a, statistically significant (p < 0.05) as
compared with group 1; b, statistically significant (p < 0.05) as compared with group 2; c, statistically significant (p < 0.05) as
compared with group 3; d, statistically significant (p < 0.05) as compared with group 4.
Fig. 6 – Atherogenic indices of experimental groups.
Values = mean ± SD; n = 5. a, statistically significant
(p < 0.05) as compared with group 1; b, statistically
significant (p < 0.05) as compared with group 2; c,
statistically significant (p < 0.05) as compared with group 3;
d, statistically significant (p < 0.05) as compared with
group 4.
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untreated diabetic group indicating diabetes. However, the pan-
creatic beta cells were not totally destroyed indicating an early
stage of diabetes. Impairment of insulin secretion and beta cell
function has been linked to shrinkage of the pancreatic β cells
as evident in Figs. 2 and 5. Insulin resistance then sets in.These
features greatly affect the long term control of blood glucose
leading to diabetic complications (Kaku, 2010). Treatment with
both doses led to restoration of shrunk beta-cells which cor-
roborates with the reduced blood glucose level, insulin
resistance and improved beta-cell function.
5. Conclusion
Treatment with the developed beverage led to reduced blood
glucose, more or less appropriate serum insulin, and in-
creased high-density-lipoprotein cholesterol levels in diabetic
rats, thus revealing an antidiabetic potential. This may be as
a consequence of modulation of the β-cell function, reduc-
tion of insulin resistance and preservation/restoration of β-cell
integrity. However, only treatment at 5.00 ml/kg bw had con-
clusive beneficial effects. The beverage can thus be used as an
adjunct drink in the treatment and management of diabetes.
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Fig. 7 – Histological examinations of experimental rat pancreas (haematoxylin and eosin stains ×400). (a) Normal control rat
pancreas showing patches of abundant β-cells. (b) Pancreas of untreated (diabetic) groups showing reduced number of
pancreatic β-cells. (c) Pancreatic tissues of treatment group administered single dose of the beverage showing pancreatic
β-cells almost similar to that of control. (d) Pancreatic tissues of the treatment group administered double dose showing
increased number of pancreatic β-cells. Legend: The arrow head refers to islets of Langerhans, while the triangle indicates
the exocrine portion.
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